The U.S. Food and Drug Administration (FDA) on July 28 released a draft guidance paper that included recommendations for the content and presentation of patient labeling information for LASIK device labels.

Israel-based Belkin Vision announced that it has received CE Mark for its Eagle device, making it the first automated, non-contact glaucoma laser treatment available within Europe.

Oertli's OS 4 platform is a powerful, multifaceted system designed for retinal, glaucoma, and cataract surgeries. At its core lies a 3-pump mechanism featuring vacuum and flow regulation, as well as a novel SPEEP pump.

MydCombi is a drug-device combination solution that uses the investigational Optejet drug delivery technology to deliver the company's unique, first-in-class combination of tropicamide and phenylephrine for in-office pupil dilation (mydriasis).

Samsara Vision announced the first three successful clinical cases in Italy using its SING IMT (Smaller-Incision New-Generation Implantable Miniature Telescope) for people living with late-stage, age-related macular degeneration (AMD).

LENSAR announced that the U.S. Food and Drug Administration (FDA) has accepted its 510(k) submission for its next-generation ALLY Adaptive Cataract Treatment System for substantive review.

Haag-Streit announced the launch of the Imaging Module 910 slit lamp. The device is instantly ready by the turn of a knob and does not require using software. Haag-Streit says capturing images is equally easy—pressing the camera trigger button is all that

Icare USA announced 510(k) clearance from the FDA for their next generation self-tonometer, the iCare HOME2.

DORC International has announced 510(k) market clearance and the launch of the Eva Nexus.

Nova Eye Medical announced the launch of its next generation canaloplasty device, iTrack Advance, in select markets in Europe and the Asia Pacific.